Nektar (NKTR) Shares Resume Trading Up 10%
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Join SI Premium – FREE
Shares of Nektar (Nasdaq: NKTR) have resumed trading up about 10 percent upon resumption following news the company will sell the royalties for Cimzia and Mircera for $124 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Nektar Therapeutics (NKTR) at Neutral
- UBS flags this name, sees "significant potential for stock outperformance"
- Mizuho TMT specialist flags 2 tech stocks to buy
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
